Pernix Therapeutics Holdings, Inc. (PTX)


Pernix Therapeutics Holdings, Inc. (PTX)

$0.21 USD

0.01 (-4.55%)

Updated Mar 4 8:00pm

Add PTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

PTX Daily Price Range
PTX 52-Week Price Range

PTX Stock Chart More Charts


PTX Price/Volume Stats

Current price $0.21
Prev. close $0.22
Day low $0.20
Day high $0.24
50-day MA $0.52
200-day MA $1.23
52-week high $3.30
52-week low $0.20
Volume 1,010,500
Avg. volume 2,010,779
Dividend yield N/A
Market Cap 3.05M

Pernix Therapeutics Holdings, Inc. (PTX) Company Bio


Pernix Therapeutics Holdings, Inc. develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product. The company was founded in 1996 and is based in Morristown, New Jersey.





PTX News Stream


Event/Time News Detail
Loading, please wait...

PTX Social Stream


Loading social stream, please wait...

View Full PTX Social Stream

PTX Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year -73.75%
3-year -63.79%
5-year -97.19%
YTD -50.00%
2018 -82.50%
2017 23.71%
2016 -34.24%
2015 -68.58%
2014 272.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8233 seconds.